Your browser doesn't support javascript.
loading
The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.
Santti, Kirsi; Beule, Annette; Rönty, Mikko; Ihalainen, Hanna; Tarkkanen, Maija; Blomqvist, Carl.
Afiliação
  • Santti K; a Department of Oncology, Comprehensive Cancer Center , Helsinki University Hospital and University of Helsinki , Helsinki , Finland.
  • Beule A; a Department of Oncology, Comprehensive Cancer Center , Helsinki University Hospital and University of Helsinki , Helsinki , Finland.
  • Rönty M; b Department of Pathology , HUSLAB and University of Helsinki , Helsinki , Finland.
  • Ihalainen H; a Department of Oncology, Comprehensive Cancer Center , Helsinki University Hospital and University of Helsinki , Helsinki , Finland.
  • Tarkkanen M; c Department of Plastic Surgery , Helsinki University Hospital and University of Helsinki , Helsinki , Finland.
  • Blomqvist C; a Department of Oncology, Comprehensive Cancer Center , Helsinki University Hospital and University of Helsinki , Helsinki , Finland.
Acta Oncol ; 58(6): 897-900, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30905251

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Purinas / Protocolos de Quimioterapia Combinada Antineoplásica / Fibromatose Agressiva / Polipose Adenomatosa do Colo / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Aminopiridinas / Neoplasias Abdominais Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Purinas / Protocolos de Quimioterapia Combinada Antineoplásica / Fibromatose Agressiva / Polipose Adenomatosa do Colo / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina / Aminopiridinas / Neoplasias Abdominais Idioma: En Ano de publicação: 2019 Tipo de documento: Article